Adverse Effects
Novaluron
CAS No.
116714-46-6
 
 

Return to Novaluron Index Page

Activity: Insecticide (Benzoylurea)
Structure:

Adverse Effects:
Anemia
Blood
Body Weight Decrease
CNS
Endocrine: Testes
Liver
Reproductive and Developmental
Spleen
ENVIRONMNETAL

NOTE: Toxicology Summary... The main toxicological effect noted in the animal database was oxidative stress and destruction of red blood cells (RBCs), most likely due to the action of an aniline metabolite (3-chloro-4-(1,1,2-trifluoromethoxy) aniline).... (page 10)
Ref: Pro
posed Registration Decision. PRD2006-05. Health Canada Pest Management Regulatory Agency. December 22, 2006.
http://www.fluorideaction.org/pesticides/novaluron.canada.12-22-06.pdf

On June 2, 2004, US EPA established first-time tolerances for the residues of Novaluron in or on 65 food commodities - see list at http://www.fluorideaction.org/pesticides/mrl.novaluron.htm


... The highest level among the tissue concentrations was found in the fat, followed by liver, kidney, pancreas, and lymph node. Compared with the animals treated with a Single Low Dose, the tissue concentrations in the animals with a Single High Dose were about 50 to 90 times higher with a 500-fold increase in dosage. Concerning the tissue concentrations, they had a 3 to 5-fold increase in the animals with Repeated administrations, compared with those in the animals with a Single Low Dose. The half-lives (hereinafter “DT50”) of the radioactivity in the fats after the treatment with the Repeated Low Dose were 52 h in males and 56 h in females. The facts that NOVALURON is not relatively metabolized easily, and that the unchanged substances mainly distribute in fat tissue because of its high LogPow (4.3), is retained there, and is eliminated only slowly from the tissues, are assumed to result in the high level of concentration in the fats... [page 5]
Ref: December 2003: Evaluation Report NOVALURON. Japan Food Safety Commission. Pesticides Expert Committee.


Anemia (click on for all fluorinated pesticides)

From Table 2.--Summary of Toxicological Dose and Endpoints for novaluron for Use in Human Risk Assessment:
-- Chronic dietary (All populations); Long-term inhalation (>6 months) and Long-term dermal (>6months). Combined chronic toxicity carcinogenicity feeding in rat LOAEL = 30.6 mg/kg/day based on erythrocyte damage and turnover resulting in a regenerative anemia.
Re: June 2, 2004. Novaluron; Pesticide Tolerance. Final Rule. Federal Register.
http://www.fluoridealert.org/pesticides/novaluron.fr.june.2.2004.htm

Blood (click on for all fluorinated pesticides)

Toxicology Summary... The main toxicological effect noted in the animal database was oxidative stress and destruction of red blood cells (RBCs), most likely due to the action of an aniline metabolite (3-chloro-4-(1,1,2-trifluoromethoxy) aniline). As a result of erythrocyte destruction, secondary effects were observed in associated blood tissues/organs and included pigmentation in Kupffer cells in the liver as well as macrophages in the spleen. At higher doses, the effect on red blood cell parameters was of a sufficient magnitude to result in hemolytic anaemia and provoke a regenerative response as evidenced by an increase in reticulocytes, Howell-Jolly Bodies and/or Heinz bodies, with accompanying hyperplastic response in the bone marrow and spleen... (pages 10-11)
Ref: Proposed Registration Decision. PRD2006-05. Health Canada Pest Management Regulatory Agency. December 22, 2006.
http://www.fluorideaction.org/pesticides/novaluron.canada.12-22-06.pdf

-- SUBCHRONIC STUDIES (Oral) 52846-002; 174427; " 'Rimon' Technical: Toxicity Study by Dietary Administration to CD Rats for 13 Weeks Followed by a 4 Week Reversibility Period"; (P.W. East; Huntingdon Life Sciences Ltd, Eye, Suffolk, England; Report No. MAK399/972319; 4/2/98); Ten CD rats/sex/group were fed 0, 50, 100, 10000 or 20000 ppm of Rimon Technical (Novaluron Technical) (batch no. 031068069, purity: 99.8% (pre-study analysis)) in the diet for 13 weeks ((M): 0, 4.2, 8.3, 818.5, 1666.9 mg/kg/day, (F): 0, 4.7, 8.9, 871.0, 1820.6 mg/kg/day). An additional 5 animals/sex/group in the 0, 50 and 20000 ppm groups were maintained for 4 more weeks after the termination of dosing in order to assess the reversibility of treatment-related effects. No treatment-related mortality resulted. No treatment-related effects on clinical signs, food consumption or body weight were evident. The red blood cell was the target of toxicity. The mean red blood cell count was decreased in a dose-related manner ((M) 10000 ppm and above, p<0.001 at 10000 ppm), (F) 50 ppm and above, p<0.05 at 50 ppm). Likewise, hemoglobin content was decreased in a dose-related manner ((M) 10000 ppm and above, p<0.01 at 10000 ppm, (F) 100 ppm and above, p<0.001 at 100 ppm). For the females the packed cell volume was lower for the 100 ppm treatment group and above (p<0.001). In conjunction with these effects on the red blood cells, the % of methemoglobin was increased in the 10000 and 20000 ppm groups (p<0.001). As a response to this effect, the % of reticulocytes was increased in these two groups (p<0.05 or p<0.001)...
-- DERMAL: 52846-038; 178971; " 'Rimon' Technical: Toxicity Study by Dermal Administration to CD Rats for 4 Weeks"; (P.B. Rees; Huntingdon Life Sciences Ltd, Eye, Suffolk, England; Project ID. MAK/478; 9/14/98); The skin of 5 CD rats/sex/group was treated with 0, 75, 400 or 1000 mg/kg/day of RIMON Technical (batch no. 970211/4, purity: 99.7%) for 6 hours/day for 28 days. The test material was suspended in 1.0% (w/v) aqueous methylcellulose. No mortality resulted from the treatment. The mean body weight and food consumption values for the 1000 mg/kg group males were less than those of the control animals. The methemoglobin concentration was greater for the 1000 mg/kg males (p<0.05) and the 400 (p<0.01) and 1000 mg/kg (p<0.001) females. No treatment-related effects were noted in the ophthalmology, clinical chemistry, or urinalysis. There were no treatment-related lesions in either the gross or microscopic examinations. No adverse effect indicated. NOEL: (Systemic) (M) 400 mg/kg/day (based upon the lower mean body weight and food consumption and increased methemoglobin level noted for the 1000 mg/kg males) (F) 75 mg/kg/day (based upon increased methemoglobin level noted for the 400 mg/kg females); (Dermal) 1000 mg/kg/day (no effect evident at the highest dose tested). Study acceptable. (Moore, 3/20/01)
Ref: 2001. Summary of Toxicology Data for Novaluron. California Environmental Protection Agency, Department of Pesticide Regulation, Medical Toxicology Branch. Chemical Code # 5754, Tolerance # 52846 3/23/01.

http://www.fluoridealert.org/pesticides/Novaluron.CAepa.ToxTst.2001.pdf

-- Short-term incidental oral (1-30 days); Intermediate-term incidental oral (1-6 months); and Intermediate-term inhalation (1 to 6 months): 90-day feeding study in rat. LOAEL = 8.64 mg/kg/day based on clinical chemistry (decreased hemoglobin, hematocrit and RBC counts) and histopathology (increased hematopoiesis and hemosiderosis in spleen and liver).
Re: June 2, 2004. Novaluron; Pesticide Tolerance. Final Rule. Federal Register.
http://www.fluoridealert.org/pesticides/novaluron.fr.june.2.2004.htm

Body Weight Decrease (click on for all fluorinated pesticides)

-- DERMAL: 52846-038; 178971; " 'Rimon' Technical: Toxicity Study by Dermal Administration to CD Rats for 4 Weeks"; (P.B. Rees; Huntingdon Life Sciences Ltd, Eye, Suffolk, England; Project ID. MAK/478; 9/14/98); The skin of 5 CD rats/sex/group was treated with 0, 75, 400 or 1000 mg/kg/day of RIMON Technical (batch no. 970211/4, purity: 99.7%) for 6 hours/day for 28 days. The test material was suspended in 1.0% (w/v) aqueous methylcellulose. No mortality resulted from the treatment. The mean body weight and food consumption values for the 1000 mg/kg group males were less than those of the control animals. The methemoglobin concentration was greater for the 1000 mg/kg males (p<0.05) and the 400 (p<0.01) and 1000 mg/kg (p<0.001) females. No treatment-related effects were noted in the ophthalmology, clinical chemistry, or urinalysis. There were no treatment-related lesions in either the gross or microscopic examinations. No adverse effect indicated. NOEL: (Systemic) (M) 400 mg/kg/day (based upon the lower mean body weight and food consumption and increased methemoglobin level noted for the 1000 mg/kg males) (F) 75 mg/kg/day (based upon increased methemoglobin level noted for the 400 mg/kg females); (Dermal) 1000 mg/kg/day (no effect evident at the highest dose tested). Study acceptable. (Moore, 3/20/01)
Ref: 2001. Summary of Toxicology Data for Novaluron. California Environmental Protection Agency, Department of Pesticide Regulation, Medical Toxicology Branch. Chemical Code # 5754, Tolerance # 52846 3/23/01.
http://www.fluoridealert.org/pesticides/Novaluron.CAepa.ToxTst.2001.pdf

CNS (click on for all fluorinated pesticides)

52846-001; 174426; " 'Rimon' Technical: Neurotoxicity Study by a Single Oral Gavage Administration to CD Rats Followed by a 14-Day Observation Period"; (A. Broadmeadow, W.D. Harvey and M.J. Collier; Huntingdon Life Sciences Ltd, Huntingdon, Cambridgeshire, PE18 6ES, England; Report No. MAK 480/983207; 2/3/99); Ten CD rats/sex/group were dosed orally by gavage with 0, 200, 650 or 2000 mg/kg of Rimon Technical (Novaluron Technical) (batch no. 970211/4; purity: 99.3%). The animals were examined in the functional observational battery (FOB) and motor activity assessments prior to dosing, on day 1 (at one hour post-dose) and on days 8 and 15. Five animals/sex/group in the control and high dose group were chosen for histological evaluation of the nervous system and muscle. No mortality resulted from the treatment. The incidence of the clinical signs, piloerection and irregular or fast breathing occurred in a dose-related manner for all of the treatment groups between days 3 and 5 post-dose. Among the parameters evaluated in the FOB and the motor activity measurements, only the forelimb grip strength was apparently affected by the treatment. The mean forelimb grip strength of the 2000 mg/kg males was less than that of the control animals at 1 hour post-dose (p<0.05). There was an increased incidence of degenerated fibers (minimal) in the peripheral nerves of the high dose group (M: (0) 0/5 vs. (2000) 2/5, F: (0) 1/5 vs. (2000) 3/5). Possible adverse effect: increased incidence of degenerated fibers in the peripheral nerves. The study data were insufficient to establish a NOEL for neurotoxicity. Acute NOEL: < 200 mg/kg (based upon the incidence of clinical signs in the 200 mg/kg group). Study unacceptable, possibly upgradeable to acceptable with the submission of histopathology data for the 200 and 650 mg/kg treatment groups. (Moore, 11/2/00)
Ref: 2001. Summary of Toxicology Data for Novaluron. California Environmental Protection Agency, Department of Pesticide Regulation, Medical Toxicology Branch. Chemical Code # 5754, Tolerance # 52846 3/23/01.
http://www.fluoridealert.org/pesticides/Novaluron.CAepa.ToxTst.2001.pdf

Liver (click on for all fluorinated pesticides)

-- Short-term incidental oral (1-30 days); Intermediate-term incidental oral (1-6 months); and Intermediate-term inhalation (1 to 6 months): 90-day feeding study in rat. LOAEL = 8.64 mg/kg/day based on clinical chemistry (decreased hemoglobin, hematocrit and RBC counts) and histopathology (increased hematopoiesis and hemosiderosis in spleen and liver).
-- Chronic toxicity - dog
. NOAEL= 10 mg/kg/day. LOAEL=100 mg/kg/day
based on hemat
ologic changes associated with histopathological changes in liver
and spleen.
-- Short-term, Intermediate-term and Long-term inhalation: LOAEL = 8.64 mg/kg/day based on clinical chemistry (decreased hemoglobin, hematocrit and RBC counts) and histopathology (increased hematopoiesis and hemosiderosis in spleen and liver)
Re: June 2, 2004. Novaluron; Pesticide Tolerance. Final Rule. Federal Register.
http://www.fluoridealert.org/pesticides/novaluron.fr.june.2.2004.htm

Reproductive and Developmental (click on for all fluorinated pesticides)

Excerpt from Table 1.--Subchronic, Chronic, and Other Toxicity
-- Reproduction and fertility- rat. NOAEL (M/F)= 74.2>=1009.8 mg/kg/day; LOAEL= 297.5 mg/kg/ day based on decreased epididymal sperm counts and increased age of preputial separation in the F1 generation, reproductive LOAEL for females was not established.
Re: June 2, 2004. Novaluron; Pesticide Tolerance. Final Rule. Federal Register.
http://www.fluoridealert.org/pesticides/novaluron.fr.june.2.2004.htm

The NOAEL for developmental toxicity was also less than 74.2 mg/kg bw/day on the basis of decreased lactational body weight gain, and increased spleen and liver weight in both F1 and F2 pups observed at this dose level. When adult and offspring spleen weights were compared, adults appeared to be more sensitive to the effects of treatment. However, the offspring would have received the treatment (via milk and a small portion in diet during the latter portion of the lactation phase) for 21 days only, compared to the parental treatment duration of 17 weeks. The NOAEL for reproductive toxicity was set at 74.2 mg/kg bw/day on the basis of decreased epididymal sperm count and delayed sexual maturation in the F1 males at 297.5 mg/kg bw/day. Overall, Novaluron was not considered to cause selective toxicity to the developing young. (PAGE 13)
Ref: Proposed Registration Decision. PRD2006-05. Health Canada Pest Management Regulatory Agency. December 22, 2006.
http://www.fluorideaction.org/pesticides/novaluron.canada.12-22-06.pdf

Spleen (click on for all fluorinated pesticides)

-- SUBCHRONIC STUDIES (Oral) 52846-002; 174427; " 'Rimon' Technical: Toxicity Study by Dietary Administration to CD Rats for 13 Weeks Followed by a 4 Week Reversibility Period"; (P.W. East; Huntingdon Life Sciences Ltd, Eye, Suffolk, England; Report No. MAK399/972319; 4/2/98); Ten CD rats/sex/group were fed 0, 50, 100, 10000 or 20000 ppm of Rimon Technical (Novaluron Technical) (batch no. 031068069, purity: 99.8% (pre-study analysis)) in the diet for 13 weeks ((M): 0, 4.2, 8.3, 818.5, 1666.9 mg/kg/day, (F): 0, 4.7, 8.9, 871.0, 1820.6 mg/kg/day). An additional 5 animals/sex/group in the 0, 50 and 20000 ppm groups were maintained for 4 more weeks after the termination of dosing in order to assess the reversibility of treatment-related effects... Microscopic examination of the spleen revealed increased extramedullary erythropoesis (50 ppm and above) and increased hemosiderosis ((M) 10000 ppm and above (p<0.01), (F) 50 ppm and above (p<0.05 at 50 ppm). In the livers of the 10000 and 20000 ppm females, pigmented Kupffer cells were noted (p<0.05 at 10000 ppm). At the conclusion of the 4 week recovery period, the methemoglobin levels were still slightly elevated for the 20000 ppm group (p<0.05), the relative spleen weight was increased for the 20000 ppm females (p<0.05), and there was still increased hemosiderosis in the spleen of the 20000 ppm females (p<0.01). No adverse effect indicated. NOEL: (M/F) < 50 ppm ((M) 4.2 mg/kg/day, (F) 4.7 mg/kg/day (based upon the increased incidence of splenic extramedullary erythropoesis noted for the 50 ppm treatment group); Study acceptable. (Moore, 11/1/00)
Ref: 2001. Summary of Toxicology Data for Novaluron. California Environmental Protection Agency, Department of Pesticide Regulation, Medical Toxicology Branch. Chemical Code # 5754, Tolerance # 52846 3/23/01.
http://www.fluoridealert.org/pesticides/Novaluron.CAepa.ToxTst.2001.pdf

-- Short-term incidental oral (1-30 days); Intermediate-term incidental oral (1-6 months); and Intermediate-term inhalation (1 to 6 months): 90-day feeding study in rat. LOAEL = 8.64 mg/kg/day based on clinical chemistry (decreased hemoglobin, hematocrit and RBC counts) and histopathology (increased hematopoiesis and hemosiderosis in spleen and liver).
-- Reproduction and
fertility- rat. Parental NOAEL= Not established; LOAEL
(M/F)= 74.2/84.0 mg/kg/day based on
increased absolute and relative spleen weights. Offspring NOAEL= Not established; LOAEL (M/F)= 74.2/84.0 mg/
kg/day based on increased abs
olute and relative spleen weights.

Re: June 2, 2004. Novaluron; Pesticide Tolerance. Final Rule. Federal Register.
http://www.fluoridealert.org/pesticides/novaluron.fr.june.2.2004.htm

Testes (click on for all fluorinated pesticides)

Excerpt from Table 1.--Subchronic, Chronic, and Other Toxicity
-- Reproduction and fertility- rat. NOAEL (M/F)= 74.2>=1009.8 mg/kg/day; LOAEL= 297.5 mg/kg/ day based on decreased epididymal sperm counts and increased age of preputial separation in the F1 generation, reproductive LOAEL for females was not established.
Re: June 2, 2004. Novaluron; Pesticide Tolerance. Final Rule. Federal Register.
http://www.fluoridealert.org/pesticides/novaluron.fr.june.2.2004.htm

Environmental (click on for all fluorinated pesticides)

PAGE 30: ...Novaluron is bioaccumulative. The n-octanol–water partition coefficient (log Kow) is 4.3, which is below the TSMP Track-1 cut-off criterion of $5.0. However, studies have determined that the bioconcentration factor (BCF) is between 14220x and 14645x that of the concentration in water, which is greater than the TSMP Track-1 cut-off criterion of BCF ≥ 5000.

PAGE 4: Novaluron presents high risks to freshwater and marine aquatic invertebrates, and moderate risk to marine mollusks. There is also some risk to susceptible non-target plant species. Beneficial insects, such as, predatory mites, parasitoid wasps, and honeybees may be temporarily suppressed. Therefore, hazard statements and specific instructions to reduce spray drift to terrestrial insects are provided on the product label. Depending on the type of application equipment, timing of spray, and crop, the buffer zones may vary from 3 to 80 metres for freshwater/estuarine aquatic organisms, and 1 to 30 metres for non-target terrestrial plant species.

PAGE 26: The aquatic risk assessment of novaluron, Rimon 10 EC, and 275-352I identified areas of concern, particularly with aquatic invertebrates (benthic and pelagic) and marine mollusks. Therefore, mitigation measures, by way of buffer zones and environmental hazard statements, are required for the protection of these organisms. The most sensitive endpoint chosen for the buffer zone calculations was the chronic daphnia. This endpoint was chosen because it affords greater protection for freshwater benthic invertebrates (gammarids), which were more sensitive than daphnia in a community microcosm study. In this study, the daphnia fully recovered, however, gammarids were completely eliminated and experienced no recovery whatsoever. Buffer zones to protect aquatic organisms range from 3 to 80 metres, depending on the crop, application method, type of habitat, and stage of growth.

PAGE 20: ... A log Kow of 4.3 indicates the potential for novaluron bioaccumulation, which is supported by two bioconcentration studies. In these studies, novaluron was readily accumulated by fish during exposure. Novaluron steady state concentrations were attained within 21-35 days, with bioconcentration factors of 14220-14645x for the whole body. The clearance pattern from the whole body was first-order with half-lives of 11-14 days. Approximately 40 days were required for 95% novaluron depuration from the whole body. The relatively high level of novaluron bioconcentration by fish, its resistance to significant transformation and its slow rate of loss during depuration suggest that it may have some potential for persistence in the aquatic food chain, particularly when frequent applications are made.

PAGES 25-26:... Using the corresponding expected concentration of novaluron in water still led to risk quotients higher than one for all organisms identified as being at risk under a worst-case scenario (Table 4.4, Appendix I). Further refinement in the assessment involved the determination of risk at the novaluron solubility limit (3.4 ?g/L), as free-swimming aquatic organisms are not expected to be exposed to concentrations beyond this value. Even at novaluron concentrations as low as the solubility limit (3.4 ?g/L), however, aquatic invertebrates, mollusks, and microcosm communities continue to be at risk from acute and/or chronic exposures with risk quotients greater than one by one to two orders of magnitude (Table 4.4, Appendix I). Following the risks of novaluron toxicity to aquatic invertebrates and mollusks at the solubility limit, a refined assessment was conducted. Accordingly, the most likely routes of novaluron entry into water are primarily through drift and surface water runoff. Therefore, risks to these above organisms were determined at expected environmental concentrations based on a runoff simulation model, with 10% drift taken into account, for apple/pear and potato applications. The simulated water body consisted of a 1 ha wetland with an average depth of 80 cm and a 10 ha drainage area. From the simulation, peak concentrations for apple/pear and potato applications in runoff water were 1.64 and 0.77 ?g a.i./L, respectively 6. Corresponding peak sediment interstitial water concentrations were 113 and 77 ng a.i./L 7. At these expected concentrations, free-swimming aquatic invertebrates, such as daphnia, remain at risk to novaluron, resulting from acute and chronic exposures, at both apple/pear and potato application rates; risk quotients range from 3.8 to 8.4 (Table 4.4, Appendix I). Based on both free-water and sediment interstitial pore-water concentration simulations, risks also remain for significant impacts to microcosm communities, including both free-swimming and sediment-dwelling aquatic invertebrates (pelagic and benthic), resulting immediately after a simulated application (peak) and after longer term exposures (>90 days) for apple/pear and potato uses; risk quotients range from 1.3 to 33 (Table 4.4, Appendix I). There is risk to marine mollusks, after 21 days of exposure simulation, only when novaluron is applied on potatoes. In general, aquatic invertebrates that live in or on freshwater lake, river, or estuarine sediments are particularly susceptible and at risk considering that all aspects of their life cycles are spent in direct contact with sediment and associated interstitial water for an indefinite period of time, and that novaluron rapidly dissipates from the water phase to the sediment phase (Figure 4.1, Appendix I).
Ref: Proposed Registration Decision. PRD2006-05. Health Canada Pest Management Regulatory Agency. December 22, 2006.
http://www.fluorideaction.org/pesticides/novaluron.canada.12-22-06.pdf

 
Fluoride Action Network | Pesticide Project | 315-379-9200 | pesticides@fluoridealert.org